Clinical Trial Update: Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Maxalt (rizatriptan) 10 mg with caffeine 75 mg for acute treatment of migraine with and without aura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• Caffeine (caffeine)
• Maxalt (Rizatriptan)

Snippet

Sponsor: Diamond Headache Clinic | Conditions: Migraine With Aura, Migraine Without Aura | Phase 3 | Status: COMPLETED